V8Y.SI Quantum Healthcare SES after-hours volume spike 13 Mar 2026: liquidity signal

A sharp after-hours volume spike pushed V8Y.SI stock into focus on 13 Mar 2026, with 1,000,700.00 shares trading versus an average of 289,150.00. The listed company, Quantum Healthcare Limited (V8Y.SI) on the SES in Singapore, held price at S$0.001. The trading surge and a rel. volume of 15.03 suggest a liquidity-driven move rather than a clear earnings trigger.

Volume spike detail for V8Y.SI stock

The post-close session recorded 1,000,700.00 shares traded, up from an avg volume of 289,150.00. That produces a relative volume of 15.03. A volume jump this size on a microcap with market cap S$8,014,501.00 typically signals either short-covering, a block trade, or speculative buying. There was no concurrent earnings release or SEC-style filing noted at the time.

Price, liquidity and exchange context for V8Y.SI stock

Quantum Healthcare (V8Y.SI) closed at S$0.001 after hours, matching the day low and previous close. The 50-day average price is S$0.00104 and the 200-day average is S$0.00124. Year high is S$0.002 and year low is S$0.001. On the SES in Singapore, microprice levels magnify percentage moves but limit absolute value swings.

Fundamental snapshot and risks for V8Y.SI stock

Quantum Healthcare shows strained liquidity with a current ratio of 0.25 and negative book value per share S$-0.00042. Enterprise value is S$14,672,501.00 and debt-to-market-cap sits at 0.86. Profitability metrics remain negative: net income per share S$-0.00023 and operating margin near -11.82%. These figures highlight solvency and valuation risks for investors.

Technical signals and volume-driven trading in V8Y.SI stock

Momentum indicators are muted: RSI is 47.95 while ADX reads 78.11, indicating a strong directional trend in volume, not price. On-balance volume is -1,302,000.00, reflecting prior outflows. For small-cap tape, a big ADX plus volume spike often precedes erratic short-term price moves. Traders should expect high volatility and low liquidity at S$0.001.

Meyka AI grade, analyst view and valuation for V8Y.SI stock

Meyka AI rates V8Y.SI with a score out of 100: Meyka AI assigns a score of 68.96 (Grade B) with a HOLD suggestion. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Independent company rating data dated 12 Mar 2026 lists a company rating of C with a sell recommendation on some quantitative screens.

Meyka AI’s forecast and price targets for V8Y.SI stock

Meyka AI’s forecast model projects S$0.01022 in one year, S$0.02820 in three years, and S$0.04617 in five years. Compared with the current price of S$0.001, the one-year implied upside is 922.34% and the three-year upside is 2,720.03%. Forecasts are model-based projections and not guarantees. Given current fundamentals, these projections assume meaningful operational improvement or capital events.

Final Thoughts

Key takeaways for V8Y.SI stock: the after-hours session on 13 Mar 2026 recorded 1,000,700.00 shares traded, a rel. volume of 15.03, and no price change from S$0.001. The spike reflects liquidity rotation in a microcap rather than confirmed fundamental news. Financials show tight liquidity with a current ratio of 0.25 and negative book value, raising solvency risk. Meyka AI assigns V8Y.SI a score of 68.96 (Grade B, HOLD) and projects S$0.01022 in one year, implying ~922.34% upside from today’s price. Investors should weigh high modelled upside against real operational risks and the low trading float. Use cautious position sizing and monitor official filings and block-trade reports; the next catalyst to watch is any management update or capital raise announcement. Meyka AI, an AI-powered market analysis platform, will track follow-up volume and filings for further signals.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.